Tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis, is stimulated by N-terminal phosphorylation by several kinases and inhibited by protein serine/threonine phosphatase 2A (PP2A). PP2A is a family of heterotrimeric holoenzymes containing one of more than a dozen different regulatory subunits. In comparison with rat forebrain extracts, adrenal gland extracts exhibited TH hyperphosphorylation at Ser 19 , Ser 31 , and Ser 40 , as well as reduced phosphatase activity selectively toward phosphorylated TH. Because the B  regulatory subunit of PP2A is expressed in brain but not in adrenal glands, we tested the hypothesis that PP2A/B  is a specific TH phosphatase. In catecholamine-secreting PC12 cells, inducible expression of B  decreased both N-terminal Ser phosphorylation and in situ TH activity, whereas inducible silencing of endogenous B  had the opposite effect. Furthermore, PP2A/ B  directly dephosphorylated TH in vitro. As to specificity, other PP2A regulatory subunits had negligible effects on TH activity and phosphorylation in situ and in vitro. Whereas B  was highly expressed in dopaminergic cell bodies in the substantia nigra, the PP2A regulatory subunit was excluded from THpositive terminal fields in the striatum and failed to colocalize with presynaptic markers in general. Consistent with a model in which B  enrichment in neuronal cell bodies helps confine catecholamine synthesis to axon terminals, TH phosphorylation was higher in processes than in somata of dopaminergic neurons. In summary, we show that B  recruits PP2A to modulate TH activity in a tissue-and cell compartmentspecific fashion.Tyrosine hydroxylase (TH) 2 catalyzes the rate-limiting step in the biosynthesis of catecholamines (dopamine, norepinephrine, and epinephrine) from the amino acid precursor L-tyrosine (1). The enzyme consists of an N-terminal regulatory domain, a central catalytic domain, and a C-terminal association domain, which mediates tetrameric assembly (2, 3). Several kinases regulate TH activity by phosphorylating key serines in the regulatory domain (Ser 8 , Ser 19 , Ser 31 , and Ser 40 ). Best characterized is Ser 40 phosphorylation by cyclic AMP-dependent protein kinase (PKA), which markedly enhances TH catalytic activity both in vitro and in vivo by relieving feedback inhibition by the catecholamines (4 -9). Phosphorylation at Ser 19 by calcium/calmodulin-dependent kinase II (CaMKII) and at Ser 31 by proline-directed kinases has comparatively moderate effects on TH activity but can facilitate subsequent Ser 40 phosphorylation (10, 11).Although the kinases that regulate catecholamine synthesis have been studied extensively, little is know about inactivation of TH by protein Ser/Thr phosphatases. Previous studies used the phosphatase inhibitor okadaic acid to implicate PP2A as a major negative regulator of TH (12-14). However, okadaic acid also inhibits the related PP4, PP5, and PP6 catalytic subunits with high affinity (15, 16), and no information is available regarding the subunit composi...